SEC Form 4 · accession 0001144204-15-017611
Aevi Genomic Medicine, Inc. · GNMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sol J Barer
Director
Period of report
Mar 20, 2015
Accepted (ET)
Mar 23, 2015 · 6:05 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001138776
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 20, 2015 | P | 50,000 | $8.45 | A | 407,000 | D | |
| Common StockF1 | holding | — | — | — | 365,854 | I | By grantor retained annuity trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1By the Sol J. Barer 2013 Grantor Retained Annuity Trust No. IV.